Status:
COMPLETED
Assessment of Postpartum Education to Improve Compliance
Lead Sponsor:
Medstar Health Research Institute
Conditions:
Hypertension in Pregnancy
Postpartum Preeclampsia
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This is a prospective single centered randomized control study for postpartum patients diagnosed with hypertension. Participants that meet inclusion criteria will be approached while they are inpatien...
Detailed Description
The study group: postpartum women with a diagnosis of either chronic hypertension, gestational hypertension, preeclampsia without severe features, preeclampsia with severe features, chronic hypertensi...
Eligibility Criteria
Inclusion
- Postpartum with diagnosis of Hypertension is defined as chronic hypertension, gestational hypertension, preeclampsia without severe features, preeclampsia with severe features, chronic hypertension with superimposed preeclampsia with and without severe features.
- At least 18 years or older
- English speaking patient and also able to read in English
- Plan to receive postpartum care at Washington Hospital Center
Exclusion
- Women who do not intend to follow up at Washington Hospital Center
- Suffered from intrauterine fetal demise
Key Trial Info
Start Date :
September 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2021
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04486170
Start Date
September 14 2020
End Date
December 15 2021
Last Update
March 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010